Related Experiment Video
Updated: Feb 17, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes
Allison H West1, Jane E Churpek1,2
1Section of Hematology/Oncology, The University of Chicago Comprehensive Cancer Center, Chicago, IL; and.
Insights
Hematologists should suspect inherited bone marrow failure syndromes (IBMFSs) in patients with cytopenias, even with subtle presentations. This review guides screening using physical exams, lab tests, and genomics for common IBMFS diagnoses.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Background:
- Inherited bone marrow failure syndromes (IBMFSs) often present with cytopenias and congenital anomalies.
- Genomic sequencing and increased awareness reveal IBMFSs in pediatric and adult populations, including early-onset myelodysplastic syndrome (MDS).
- Distinguishing IBMFS from sporadic conditions is crucial due to differing management and outcomes.
Purpose of the Study:
- To provide a practical screening approach for hematologists to identify IBMFSs.
- To outline diagnostic tools for recognizing common IBMFSs.
Main Methods:
- Review of clinical presentations and diagnostic strategies for IBMFSs.
- Emphasis on physical examination, laboratory screening, and genomic analysis.
Main Results:
- IBMFSs are increasingly recognized, necessitating a structured diagnostic approach.
- Key IBMFSs include Fanconi anemia, telomere biology disorders, Diamond-Blackfan anemia, GATA2 deficiency syndrome, Shwachman-Diamond syndrome, and severe congenital neutropenia.
Conclusions:
- Early and accurate diagnosis of IBMFSs is critical for appropriate patient management.
- Hematologists require a systematic approach to suspect and diagnose IBMFSs using available tools.
Abstract:
Patients with inherited bone marrow failure syndromes (IBMFSs) classically present with specific patterns of cytopenias along with congenital anomalies and/or other physical features that are often recognizable early in life. However, increasing application of genomic sequencing and clinical awareness of subtle disease presentations have led to the recognition of IBMFS in pediatric and adult populations more frequently than previously realized, such as those with early onset myelodysplastic syndrome (MDS). Given the well-defined differences in clinical management needs and outcomes for aplastic anemia, acute myeloid leukemia, and MDS in patients with an IBMFS vs those occurring sporadically, as well as nonhematologic comorbidities in patients with IBMFSs, it is critical for hematologists to understand how to approach screening for the currently known IBMFSs. This review presents a practical approach for the clinical hematologist that outlines when to suspect an IBMFS and how to use various diagnostic tools, from physical examination to screening laboratory tests and genomics, for the diagnosis of the most frequent IBMFSs: Fanconi anemia, telomere biology disorders, Diamond-Blackfan anemia, GATA2 deficiency syndrome, Shwachman-Diamond syndrome, and severe congenital neutropenia.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023